Overview

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Status:
Unknown status
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
Intravitreal Bevacizumab is an effective treatment for the diffuse diabetic macular edema
Phase:
Phase 3
Details
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Treatments:
Bevacizumab